BRIACELL THERAPEUTICS CORP. Prepaid Expense, Current
BRIACELL THERAPEUTICS CORP. (BCTX) had Prepaid Expense, Current of $1.39 million as of 2025-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2025-10-16
- 2025-07-31: Prepaid Expense, Current $1.39M.
- 2024-07-31: Prepaid Expense, Current $1.32M.
- 2024-04-30: Prepaid Expense, Current $4.58M.
- 2024-01-31: Prepaid Expense, Current $5.47M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2025-07-31 | $1.39M 10-K · filed 2025-10-16 | |
| 2024-07-31 | $1.32M 10-K · filed 2025-10-16 | |
| 2024-04-30 | $4.58M 10-Q · filed 2024-06-14 | |
| 2024-01-31 | $5.47M 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $4.74M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $4.84M 10-K · filed 2024-10-29 | $5.68M 10-K · filed 2023-10-25 |
| 2023-04-30 | $1.32M 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $429.40K 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $742.12K 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $1.28M 10-K · filed 2023-10-25 | |
| 2021-07-31 | $516.89K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |